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In this study, the behavioral and electroencephalographic (EEG)
analysis of seizures induced by the intrahippocampal injection in rats
of granulitoxin, a neurotoxic peptide from the sea anemone Bunodo-
soma granulifera, was determined. The first alterations occurred
during microinjection of granulitoxin (8 µg) into the dorsal hippocam-
pus and consisted of seizure activity that began in the hippocampus
and spread rapidly to the occipital cortex. This activity lasted 20-30 s,
and during this period the rats presented immobility. During the first
40-50 min after its administration, three to four other similar short
EEG seizure periods occurred and the rats presented the following
behavioral alterations: akinesia, facial automatisms, head tremor,
salivation, rearing, jumping, barrel-rolling, wet dog shakes and fore-
limb clonic movements. Within 40-50 min, the status epilepticus was
established and lasted 8-12 h. These results are similar to those
observed in the acute phase of the pilocarpine model of temporal lobe
epilepsy and suggest that granulitoxin may be a useful tool not only to
study the sodium channels, but also to develop a new experimental
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Three decades ago, pharmacologists and
chemists were beginning to research new
marine products (1,2). Pharmacological tests
on these new toxins began with studies on
the central nervous system and ionic chan-
nels, with later studies at the level of the
heart, bowel and vascular permeability. Some
of these new substances have been used as
scientific tools to understand some aspects
of cellular biochemistry, including the ionic
channels, and others have been used as phar-
maceutical products (3).
The sea anemones occupy a prominent
position in this branch of research. These
animals possess specialized structures, the
tentacles, that contain a wide variety of tox-
ins which are used in the capture of prey, as
well as for defense against predators. Among
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these toxins, the peptides that act by binding
to the ionic channels, especially to the volt-
age-gated sodium channels, are the sub-
stances most extensively studied and charac-
terized (4). They act similarly to a-scorpion
toxins, inhibiting the inactivating phase of
sodium currents during depolarization and
stabilizing sodium channels in the open state
without affecting the activation process (5).
The sea anemone peptides have been classi-
fied into four classes according to their struc-
tural characteristics (4): a) type 1 class, com-
prising long polypeptides isolated from the
genera Anthopleura and Anemonia, mem-
bers of the family Actiniidae; b) type 2 class,
comprising long polypeptides isolated from
the genera Radianthys and Stichodactyla,
members of the family Stichodactylidae; c)
type 3 class, comprising long polypeptides
isolated from the genus Calliactis, and d)
type 4 class, comprising short polypeptides
isolated from the genus Parasicyonis.
These toxic sea anemone peptides may
act predominantly as cardiac stimulants or as
neurotoxins according to the degree of af-
finity with the isoforms of cardiac or neu-
ronal sodium channels (4,6). The cardiac
stimulant type 1 peptides, such as anthopleu-
rin-A, anthopleurin-B and anemone toxin
(ATX-II), have been well studied and their
possible useful applications as therapeutic
agents with a combination of positive ino-
tropic and antiarrhythmic activities in hu-
man heart diseases have been suggested (4,7).
The pharmacological effects of some
anemone peptides on the nervous system
have also been studied, such as the effect of
a central stimulant substance isolated from
the sea anemone Stoichactis kenti on mouse
brain monoamines (8), the potent excitatory
effect of anthopleurin-B on frog spinal cord
(9), the possible application of ShI as an
insecticide based on its negligible mamma-
lian neurotoxicity as compared to its potent
neurotoxicity in crustacea (4,10), the ATX-
II-induced increase in persistent sodium cur-
rent and its effects on the firing properties of
rat neocortical pyramidal neurones (11), and
the synaptosomal glutamate release induced
by fraction Bc2 from the sea anemone Buno-
dosoma caissarum venom (12).
However, still with respect to the phar-
macological effects on the central nervous
system, no electroencephalographic (EEG)
studies have been conducted thus far using
sea anemone peptides. In the present study,
the behavioral and EEG analysis of seizures
produced by granulitoxin (GRX), a new neu-
rotoxic peptide of class type 1 recently iso-
lated from the sea anemone B. granulifera
(13), was determined.
GRX from the sea anemone B. granulifera
was purified as previously described (13).
The animals used were male Wistar rats,
200-250 g in weight, housed individually
under environmentally controlled conditions
(a 12-h light/dark cycle with lights on at 6:00
am, 22-24oC, 45-55% humidity) with free
access to food and water. The rats were
anesthetized with 3 ml/kg of a Nembutal-
chloral hydrate mixture (1 g Nembutal, 4 g
chloral hydrate dissolved in 100 ml saline)
and placed in a stereotaxic frame (David
Kopf Instruments, Tujunga, CA, USA). A
unilateral guide cannula (21 gauge stainless
steel) was then chronically implanted into
the dorsal hippocampus (CA1-CA3 areas)
with the following coordinates: AP -3.3, L
+2.5, V -3.5 (14) using a rapid-setting meth-
yl methacrylate cement (Orto-Class, ClÆssico
Sªo Paulo, Sªo Paulo, SP, Brazil), that fixed
the cannulae to the skull by means of stain-
less steel anchor screws. The stainless steel
stylets terminating 0.2 mm beyond the tip of
the guide cannula kept them open prior to
microinjection. After surgery, each animal
was housed individually and allowed to re-
cover for a period of 4-5 days. The microin-
jections were performed with an injection
cannula (27 gauge) connected to a 1-µl
Hamilton syringe by a polyethylene tube.
GRX was dissolved in a volume of 1 µl and
microinjected at the rate of 0.25 µl/ml. The
injection cannula was kept in the guide can-
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nula for an additional 1 min to allow ad-
equate absorption by the surrounding tissue.
For depth EEG recordings, bipolar twisted
electrodes were stereotaxically positioned in
the dorsal hippocampus and anchored to the
skull with dental acrylate. The stereotaxic
coordinates were as follows: AP -4.3, L +2.5,
V -3.5 (14). Surface recordings were ob-
tained from jeweller screws positioned bilat-
erally over the occipital cortex. Another screw
placed in the frontal sinus served as refer-
ence electrode. The signals under investiga-
tion were amplified using a Berger electro-
encephalograph (time constant 0.03 s and
high cutoff filter 15 Hz). The rats were as-
signed at random to the experimental and
control groups (N = 4-6) and to the subse-
quent times of behavioral and EEG testing.
The EEG recordings and behavioral obser-
vations were carried out in a Plexiglas com-
partment (30 x 30 x 45 cm) between 8:00 am
and 6:00 pm. Before EEG monitoring, each
animal was individually placed in the re-
cording compartment and allowed 15 min
for habituation to the recording set-up. The
baseline EEG recordings were obtained for
15 min and then the animal was injected into
the hippocampus with GRX. Subsequently,
EEG recordings were obtained continuously
and behavior was noted for periods ranging
from 2 to 3 h following the intracerebral
microinjections. Additional recordings were
obtained between 5-6, 8-9, 11-12, 24-28,
48-52 and 72-76 h. The correct placement
of the implanted electrodes and guide can-
nulae was checked histologically in cresyl
violet-stained serial sections as previously
described (15).
The microinjection of 4 µg GRX into the
dorsal hippocampus did not produce signifi-
cant EEG or behavioral changes. However,
the first alterations occurred during the mi-
croinjection of 8 µg GRX and consisted of
seizure activity that began in the hippocam-
pus and spread rapidly to the occipital cortex
(Figure 1B). This activity lasted up to 20-30
s, and during this period the rats presented
immobility. During the first 40-50 min after
its administration, three to four other similar
short EEG seizure periods occurred (Figure
1C) and the rats presented the following
behavioral alterations: akinesia, facial auto-
matisms, head tremor, salivation, rearing,
jumping, barrel-rolling, wet dog shakes and
forelimb clonic movements. Although some
of these behavioral alterations were present
during the EEG seizure periods, they were
also observed without EEG alterations in
dorsal hippocampus and occipital cortex.
However, this does not rule out the possibil-
ity of epileptogenic potentials occurring in
other areas of the brain where the electrodes
were not implanted.
Status epilepticus was established within
40-50 min (Figure 1D) and during this pe-
riod the animals presented generalized con-
vulsions alternating with behavioral changes
similar to those that occurred during the
period of 50 min after GRX injection. Status
epilepticus lasted 8-12 h and was followed
by a progressive normalization of the EEG
and behavior that returned to the pre-GRX
administration pattern within the next 24 h.











Figure 1. Electroencephalographic recordings illustrating the changes produced by intrahip-
pocampal injection of 8 µg of granulitoxin (GRX). A, Pre-toxin control recordings; B, seizure
activity period observed 90 s before the end of GRX injection; C, seizure activity period
observed 15 min after GRX injection, and D, status epilepticus observed 50 min after GRX
injection. Records were obtained from occipital cortex (CTX) and hippocampus (HPC).
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pocampal injection of GRX (8 µg) in rats
produced epileptogenic activity and affected
animal behavior in a significant manner. Simi-
lar results were obtained with other purified
neurotoxins and venoms. Kainic acid, an
algal excitotoxin, at doses less than those
causing cell damage induced seizures of hip-
pocampal origin resembling the human com-
plex partial epilepsy arising from limbic struc-
tures (16). The total venom of the South
American rattlesnake Crotalus durissus ter-
rificus injected intrahippocampally (15) and
its purified toxins, such as crotamine (17)
injected intraventricularly, and convulxin
(18) and gyroxin (19) injected intravenously,
induced strong epileptiform effects.
Furthermore, intrahippocampal injections
of GRX in rats showed important results
similar to those observed during the acute
period after systemic administration of pilo-
carpine, a potent muscarinic agonist that has
been used to establish an experimental mo-
del of temporal lobe epilepsy (20). During
the first 30-40 min after their administration
to rats, GRX and pilocarpine produce simi-
lar behavioral signs and similar EEG changes,
and after 40-50 min, both also produce simi-
lar status epilepticus. These observations
suggest that the seizures induced by GRX
may originate, at least in part, from the same
neural systems responsible for pilocarpine
seizures in the acute period. In the future, it
will be important to investigate if GRX, like
pilocarpine, may also induce brain lesions
that are responsible for the chronic period of
seizures that may persist for a long time (6
months) (20).
The N-terminal amino acid sequence of
GRX (AKTGILDSDGPTVAGNSLSGT)
presents a partial degree of homology with
those of other toxins from sea anemones
such as B. caissarum, Anthopleura fuscovi-
ridis and Anemonia sulcata (13), suggesting
that this toxin may be classified as a class
type 1 polypeptide that seems to act by pro-
longing action potentials of excitable tissues
by slowing down the inactivation process of
the voltage-gated sodium channel (5).
In conclusion, the results presented here
suggest that GRX may be a useful tool not
only to study sodium channels, but also to
develop a new experimental model of status
epilepticus, opening new perspectives in the
field of sea anemone toxin research.
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